High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting

BACKGROUND: High-dose (HD) chemotherapy with melphalan and autologous blood stem cell transplantation (ABSCT) for treatment of symptomatic multiple myeloma (MM) on an outpatient basis has been well established in the USA and Canada, whereas in Germany and Western Europe an inpatient setting is the c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Lisenko, Katharina, Sauer, Sandra, Bruckner, Thomas, Egerer, Gerlinde, Goldschmidt, Hartmut, Hillengass, Jens, Schmier, Johann W., Shah, Sofia, Witzens-Harig, Mathias, Ho, Anthony D., Wuchter, Patrick
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5322605/
https://ncbi.nlm.nih.gov/pubmed/28228122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3137-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados